Pyridine → [2-(7-Bromo-isoquinoline-5-sulfonylamino)-ethyl]-carbamic acid tert-butyl ester
반응식
[Br:1][C:2]1[CH:3]=[C:4]([S:12](Cl)(=[O:14])=[O:13])[C:5]2[CH:6]=[CH:7][N:8]=[CH:9][C:10]=2[CH:11]=1.[C:16]([O:20][C:21](=[O:26])[NH:22][CH2:23][CH2:24][NH2:25])([CH3:19])([CH3:18])[CH3:17].N1C=CC=CC=1>C(Cl)Cl>[C:16]([O:20][C:21](=[O:26])[NH:22][CH2:23][CH2:24][NH:25][S:12]([C:4]1[C:5]2[CH:6]=[CH:7][N:8]=[CH:9][C:10]=2[CH:11]=[C:2]([Br:1])[CH:3]=1)(=[O:14])=[O:13])([CH3:19])([CH3:17])[CH3:18]참가 물질
5
실험 절차
A slurry of 7-bromo-isoquinoline-5-sulfonyl chloride (16.3 g, 35.5 mmol) in CH2Cl2 (200 mL) is added in small portions to a stirred solution of (2-amino-ethyl)-carbamic acid tert-butyl ester (6 mL, 37.9 mmol) and pyridine (2.79 mL, 34.5 mmol) in CH2Cl2 (100 mL) at 0° C. under nitrogen. The resultant mixture is allowed to stir at ambient temperature overnight. The mixture is diluted with another 100 mL CH2Cl2, washed with saturated aqueous NaHCO3 (150 mL) solution, dried, filtered and concentrated. The dark oil is subject to column chromatography (Biotage 75 short; eluted with 10-20% CH3CN/CH2Cl2+0.2% NEt3) to give the title compound as a white solid. ESIMS: m/z 430 [(M+H)+, 79Br], 432 [(M+H)+, 81Br].
후처리
- washwashed with saturated aqueous NaHCO3 (150 mL) solution
- customdried
- filtrationfiltered
- concentrationconcentrated
- washThe dark oil is subject to column chromatography (Biotage 75 short; eluted with 10-20% CH3CN/CH2Cl2+0.2% NEt3)
출처 및 근거
- ORD 기록
- ord-b389aa74b15448c4923b40c7644e820e
- 출처 데이터셋
- uspto-grants-2008_08
- 특허 번호
- US07414063B2
반응 노트
불러오는 중…